We evaluated the potential benefit of continuous positive airway pressure (CPAP) to prevent postoperative pulmonary complications (PPCs), atelectasis, pneumonia, and intubation in patients undergoing major abdominal surgery. Summary Background Data: PPCs are common during the postoperative period and may be associated with a high morbidity rate. Efficacy of CPAP to prevent PPCs occurrence is controversial. Methods: Medical literature databases were searched for randomized controlled trials examining the use of CPAP versus standard therapy in patients undergoing abdominal surgery. The meta-analysis estimated the pooled risk ratio and the number needed to treat to benefit (NNTB) for PPCs, atelectasis, and pneumonia. Results: The meta-analysis was carried out over 9 randomized controlled trials. Overall, CPAP significantly reduced the risk of (1) PPCs (risk ratio, 0.66; 95% confidence interval ͓CI͔, 0.52-0.85) with a corresponding NNTB of 14.2 (95% CI, 9.9 -32.4); (2) atelectasis (risk ratio, 0.75; 95% CI, 0.58 -0.97; NNTB, 7.3; 95% CI, 4.4 -64.5); (3) pneumonia (risk ratio, 0.33; 95% CI, 0.14 -0.75; NNTB, 18.3; 95% CI,. In all cases the variation in risk ratio attributable to heterogeneity was negligible, although there was some evidence of publication bias. Conclusions: This systematic review suggests that CPAP decreases the risk of PPCs, atelectasis, and pneumonia and supports its clinical use in patients undergoing abdominal surgery. (Ann Surg 2008;247: 617-626)
METHODS

Search Strategy
We searched the OVID version of central MEDLINE from January 1966 to November 2005, EMBASE from January 1988 to 2005 week 48, CINAHL from December 1982 to November 2005 and the Cochrane Central Register of Controlled Trials for articles in any language limiting the search to "randomized controlled trials" and using the keywords "continuous positive airway pressure," "abdominal surgery" combined with any of the following: "postoperative complications," "postoperative care," "postoperative period," "respiratory therapy," "physiotherapy," "randomized controlled trials," "clinical trials," "random/allocation," "comparative studies," and "acute respiratory failure."
Selection Criteria
Selected articles met the following a priori defined criteria: (a) Study design was a RCT; (b) study population included patients older than 18 years who underwent abdominal surgery and excluded patients requiring emergency procedure (because data on efficacy of CPAP after emergency procedure, ie, data on operation that must be performed as soon as possible and no longer than 12 hours after admission are not available) or abdominal aortic aneurysm surgery (because outcome variables in these patients behave differently than those in patients undergoing abdominal surgery 20, 21 ); (c) the intervention included standard therapy (ie, physiotherapy and oxygen) plus early CPAP versus standard therapy alone. CPAP was defined as a breathing mode where the patient spontaneously breathes through a pressurized circuit against a threshold resistor that maintains a preset positive airway pressure during both inspiration and expiration. Studies that analyzed the application of CPAP in patients undergoing abdominal surgery as a part of a group of patients undergoing other surgical procedures and/or with other pathologies were excluded, as well as studies published in abstract form.
Methodological quality of the studies was evaluated scoring randomization (0 not performed in the study, 1 performed in the study), concealment, blinding, patients selection, comparability of groups at baseline, treatment protocol, analysis of confounders, explicit documentation of control of co-intervention, outcome definition, extent follow-up, and intention-to-treat analysis. The overall score ranged between 0 and 11.
Definition of the Outcomes
According to Brooks-Bronn, 4 we defined PPCs as at least 1 of the following parameters documented at any time during the first 6 postoperative days: new cough and sputum production, abnormal breath sounds as compared with baseline, temperature Ͼ38°C, chest radiograph documentation of atelectasis or new infiltrate, physician documentation of atelectasis or pneumonia. 12 Moreover, pneumonia (defined as the presence of an infiltrate that is new or progressive on chest radiograph, plus any of the following: temperature higher than 38°C or less than 36°C, with white blood cell count higher than 12 ϫ 10 3 /L or less than 3.5 ϫ 10 3 /L or 20% immature form, collection of purulent specimens, isolation and identification of a pathogenic microorganism from sputum, or blood on Gram staining or culture) 22, 23 and atelectasis (defined as chest x-ray film opacification of the lobe or lobar segment) 4,10 were identified and differentiated if possible. Intubation (defined as the airway management procedures required for initiation of mechanical ventilation because of cardiopulmonary complications) and mortality (defined as any cause of death during the study period) were also analyzed.
Data Abstraction
Independently and in duplicates, 2 of the authors (S.V. and F.G.) abstracted data from these studies to decide whether trials met the inclusion criteria. Information abstracted included the objective, patient's characteristics, study design, protocols implemented in the control and intervention groups, description of the methods used to apply CPAP, outcomes, criteria, and definitions used. Differences of opinion were solved by team consensus.
Statistical Analysis
Efficacy of CPAP was evaluated as risk reduction, along with the corresponding 95% confidence intervals (CIs), for the outcomes of interest. We estimated risk reduction for individual studies and then pooled across studies using random-effects modeling. 24 The weight given to each study has been chosen to minimize the uncertainty of the pooled effect estimate. Thus, studies with smaller standard errors were given more weight than studies with larger standard errors. In particular, we incorporated the assumption that the different studies were estimating related but different treatment effects adjusting the standard errors of the study-specific estimates according to extent of the heterogeneity among the treatment effects observed in the different studies. Results were graphically expressed as forest plots where the size of each box is proportional to the weight of the corresponding study.
We also estimated the "number needed to treat to benefit" (NNTB), ie, the number of individuals that had to be treated to avoid occurrence of PPCs, pneumonia, or atelectasis. 25 To quantify the proportion of total variation among effect estimates that is caused by heterogeneity rather than sampling error, we calculated the statistic for I 2 , which is intrinsically independent of the number of studies. 26, 27 We estimated the role of the publication bias using a graphical method (funnel plot) and a weighted regression. 28, 29 Statistical analyses were conducted using STATA version 9.1 (Stata Corp., College Station, TX).
RESULTS
Study Selection
Our initial electronic search identified 735 studies. Of these, 710 were excluded because they were not RCTs or were duplicated. The remaining 25 studies were retrieved for more detailed evaluation. Of these, some studies were excluded for the following reasons: they did not include patients undergoing abdominal surgery (n ϭ 12), 30 -41 study description did not allow to separate abdominal from other surgical procedures (n ϭ 1), 42 there was no control group (n ϭ 1), 43 study endpoints differed from those of the present study (n ϭ 2) 44, 45 (Fig. 1 ). Therefore, a total of 9 RCTs met our entry criteria. 17-19,46 -51 The main characteristics of the 9 trials are summarized in Table 1 . Eight studies were published in English, and 1 in German. They represent an international experience including data from 6 different countries. One study was multicenter 51 whereas the remaining were performed in a single center. 17-19,46 -50 The studies had a large variation in the modality of O 2 and physiotherapy administration implemented in the control group. Large variability was also observed regarding technical implementation of CPAP and timing of its application. In the trial carried out by Denehy et al, 17 CPAP was applied in 2 groups for 15 and 30 minutes. The 2 groups were hence merged into a single treatment group. The study carried out by Lotz et al 47 Our analysis included only the latter 2 groups. CPAP was administered via different noninvasive interface in 8 studies, [17] [18] [19] [47] [48] [49] [50] [51] and through the endotracheal tube in 1 study. 46 Descriptive data of the populations included in the selected trials are summarized in Table 2 . Table 3 shows the methodological quality of the 9 trials. All trials were randomized but only 3 used concealed randomization 17, 48, 51 ; none was blinded. Co-interventions were documented in 4 of the 9 trials 18,49 -51 ; intention-to-treat analysis was used in 2 studies 19, 51 ; specific criteria for outcome assessment were implemented in 8 trials. 17,19,46 -51 Only 2 trials provided data of follow-up more than 7 days. 47, 51 All but 1 provided comparability of group at baseline. 18
Assessment of Validity
Effects of CPAP on Clinical Outcomes
Only 1 of the 9 trials showed a significantly lower rate of PPCs 51 whereas 8 of others reported no difference. 17-19,46 -50 When the results of the 9 studies including 654 patients were pooled, CPAP was associated with a significantly lower rate of PPCs than standard treatment with a risk reduction of 0.34 (95% CI, 0.15-0.48), corresponding to a NNTB of 14.2 (95% CI, 9.9 -32.4; Fig. 2 ). The analysis has been repeated excluding the study carried out by Carlsson et al. 18 This study weighted for more than 37% in the estimate of the risk reduction. Nevertheless, the positive effect of CPAP was confirmed by the restricted analysis with a risk reduction of 0.41 (95% CI, 0.22-0.55).
The heterogeneity between studies was low (I 2 ϭ 14%), and the asymmetry in the funnel plot suggests missing negative small trials ( Fig. 3) . The occurrence of a publication bias was not confirmed by Egger's test (P ϭ 0.08). The study of Denehy et al 17 did not fully meet the intention-to-treat principle, because 7 subjects treated with CPAP were excluded from the analysis. We assessed the influence of this potential bias comparing the scenario in which none of the 7 excluded participants developed PPCs (risk reduction, 0.40; 95% CI, 0.20 -0.56) with the scenario in which all 7 excluded participants developed PPCs (risk reduction, 0.30; 95% CI, 0.11-0.25).
Five studies including 175 patients reported atelectasis as main outcome variable. 17, 46, 48, 49 Overall, the addition of CPAP to standard treatment was associated with a reduction of atelectasis with a risk ratio of 0.25 (95% CI, 0.03-0.42), with a corresponding NNTB of 7.3 (95% CI, 4.4 -64.5; Fig. 4 ). The analysis has been repeated excluding the study with the highest weight (54%) in the estimate of risk reduction (Carlsson et al 18 ). Nevertheless, the positive effect of CPAP was confirmed by the restricted analysis with a risk reduction of 0.35 (95% CI, 0.05-0.56).
Four trials including 506 patients reported pneumonia as main outcome variable 17, 19, 48, 51 Only 1 reported a lower rate of pneumonia with CPAP 51 whereas the remaining 3 found no difference between control and CPAP.
After we pooled study results, CPAP was found to be associated with a significant reduction of pneumonia with a Fig. 5 ).
The heterogeneity between studies in the risk reduction for atelectasis and pneumonia with CPAP was negligible, although the small number of studies considered hampered the interpretation of the I 2 . For atelectasis the funnel plot (not shown) and Egger's test suggested the presence of publication bias (P ϭ 0.003); on the contrary, for pneumonia neither the funnel plot nor Egger's test (P ϭ 0.9) showed evidence of publication bias.
Only 2 studies including 413 patients evaluated intubation rate. 19, 51 Bohner et al 19 failed to identify a statistically significant effect of postoperative CPAP (risk reduction of 0.79, with a 95% CI of 0.03-1.78). Squadrone et al 51 estimated a risk reduction associated with a postoperative CPAP of 0.89 (95% CI, 0.15-0.99). The pooled estimate, with both studies having the same weight on the result, showed a beneficial effect of postoperative CPAP (risk reduction 0.85, 95% CI, 0.34 -0.97).
Two studies assessed the effect of postoperative CPAP on mortality. 19, 51 However, the overall number of deaths among the patients treated with CPAP (n ϭ 4) and the controls (n ϭ 3) was too small to lead to a meaningful estimate.
To be conservative and to include in the analyses studies carried out in different periods and settings, we incorporated heterogeneity among studies performing random-effects meta-analyses. However, the fixed-effect approach generated comparable results: risk reduction of 0.46 (95% CI, 0.29 -0.60) for the PPCs, 0.56 (95% CI, 0.12-0.53) for atelectasis, and 0.69 (95% CI, 0.29 -0.87) for pneumonia.
DISCUSSION
This systematic review indicates the effectiveness of CPAP to reduce the risk of PPCs, atelectasis, and pneumonia in patients undergoing abdominal surgery. This study also suggests that postoperative CPAP displays a beneficial effect on the risk of endotracheal intubation. Despite advances in anesthesia and surgical care, PPCs are still a significant problem in patients undergoing abdominal surgery. 52 PPCs (usually defined as events occurring in the postoperative period producing clinical disease or dysfunctions that adversely affect the clinical course) 4 have an incidence ranging between 6% and 80% depending on the surgical site and presence of predictive risk factors. [1] [2] [3] [4] [52] [53] [54] [55] [56] In patients recovering from major abdominal surgery, PPCsrelated acute respiratory failure that requires intubation and mechanical ventilation may occur in 10% to 25% of cases, thus increasing morbidity and mortality. 55 The most evoked mechanism of PPCs-related acute respiratory failure after abdominal surgery is hypoxemia caused by atelectasis and pneumonia. 10 Development of atelectasis within the perioperative period of patients undergoing abdominal surgery is owing to rapid shallow breathing, prolonged supine position, pain and anesthesia-induced diaphragmatic dysfunction, and impaired mucociliary clearance. Incidence of atelectasis after abdominal surgery ranges between 80% and 90% 57 ; 20% to 70% of the episodes of postoperative hypoxemia after abdominal surgery are caused by atelectasis. 4, 58 Development of postoperative atelectasis and pneumonia are associated with a 30% to 50% increased risk of developing acute respiratory failure requiring mechanical ventilation. 4, 7 Recent data indicate that alveolar hypoxia may result in pulmonary vascular leak and lung inflammation through macrophages recruitment. 59 Moreover, atelectasis formation promotes both bacterial growth in the lung and its translocation from the lung into the blood stream. 60 Oxygen therapy is considered effective to treat postoperative hypoxemia. 61 However, a recent meta-analysis showed that although postoperative oxygen therapy closely controls and treats hypoxemia, there are no benefits regarding morbidity and mortality nor evidence of reduction in incidence of acute respiratory failure. 62 Decreased lung volume and atelectasis are intuitively treated by the prophylactic lung expansion most commonly obtained through incentive spirometry 63 or CPAP. 64 A recent systematic review concluded that for patients having abdominal surgery any type of lung expansion intervention is better that no prophylaxis. 65 The objective of this review was to identify the best clinical evidence available to examine the effects of CPAP in PPCs. The review process identified data sets on efficacy of CPAP treatment separated by 30 years. Although over this period of time the clinical scenario has changed due to better technology and more accurate diagnostic procedures, 66,67 our study did not show any time-related risk reduction.
The publication bias for PPCs was not clearly shown by Egger's test, although the funnel plot suggested that few small negative studies might be missing.
The publication bias that we found for atelectasis somewhat hampers the interpretation of our results. However, the presence of this bias was entirely attributable to the smallest studies included in the meta-analysis.
An important factor in this meta-analysis is that the individual RCTs did not reach significance by themselves. However, when all the studies were pooled together quantitatively, statistical significance was reached with a positive result in favor to CPAP.
Although we included in our meta-analysis a relatively small number of clinical trials 9 and patients (654), the small variation in risk reduction attributable to heterogeneity (I 2 ϭ 14%) reveals that our findings are robust. However, because of the heterogeneity between the studies included in our meta-analysis, a number of clinically relevant issues could not be addressed by our analysis. First, potential preoperative risk factors may contribute to the development of PPCs, atelectasis, and pneumonia, 68 -70 and might influence the efficacy of CPAP. In our analysis, 3 trials did not specify whether patients were preoperatively healthy, 17,47,48 1 trial included a high percentage of patients with coronary heart disease and pulmonary disease, 19 5 trials included only preoperative healthy patients, 18,46,49 -51 and 1 study included postoperatively hypoxemic patients only. Second, the trials differed in how CPAP was applied, including the type of interfaces, devices, and the duration of use.
Authors of all selected studies were asked (mailing a letter and phoning the corresponding author) whether data on mortality were available although not reported in the publi-cations. Unfortunately, most of authors did not answer nor were found at the published address; the few who responded did not report available outcome data. Future studies with appropriate accrual rate are required to evaluate the efficacy of CPAP on mortality in patients developing severe hypoxemia after abdominal surgery.
Finally, results of this meta-analysis support the findings of a recent clinical trial indicating that CPAP should be used immediately after development of postoperative hypoxemia, applied for at least 6 hours, and interrupted only when a normal oxygenation (ie, an arterial oxygen tension-toinspiratory oxygen fraction ratio Ն300) is established. 51 In conclusion, this systematic review of clinical trials of early CPAP treatment in postoperative abdominal patients suggests that, although the effect on mortality remains to be evaluated in larger studies, CPAP decreases PPCs, atelectasis, and pneumonia, supporting its use in the clinical practice.
